Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
5.669M
Cash
5.012M
Avg Qtr Burn
-1.018M
Short % of Float
4.13%
Insider Ownership
5.45%
Institutional Own.
2.09%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Arakoda Details Malaria | Approved Quarterly sales | |
SJ733 Details Malaria | Phase 2b Initiation | |
Tafenoquine Details Babesiosis | Phase 2a Initiation | |
Tafenoquine Details COVID-19 | Failed Discontinued |